JP2005504814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504814A5 JP2005504814A5 JP2003531978A JP2003531978A JP2005504814A5 JP 2005504814 A5 JP2005504814 A5 JP 2005504814A5 JP 2003531978 A JP2003531978 A JP 2003531978A JP 2003531978 A JP2003531978 A JP 2003531978A JP 2005504814 A5 JP2005504814 A5 JP 2005504814A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- perfusion
- identified
- individual
- choriocarcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 230000010412 perfusion Effects 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000006332 Choriocarcinoma Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 208000024313 Testicular Neoplasms Diseases 0.000 claims 1
- 238000012084 abdominal surgery Methods 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000037841 lung tumor Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 208000025402 neoplasm of esophagus Diseases 0.000 claims 1
- 208000025189 neoplasm of testis Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 201000003120 testicular cancer Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32628801P | 2001-10-01 | 2001-10-01 | |
| US60/326,288 | 2001-10-01 | ||
| PCT/US2002/031079 WO2003028642A2 (en) | 2001-10-01 | 2002-10-01 | Methods of inhibiting metastases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010107880A Division JP2010209101A (ja) | 2001-10-01 | 2010-05-10 | 転移阻害のための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005504814A JP2005504814A (ja) | 2005-02-17 |
| JP2005504814A5 true JP2005504814A5 (enExample) | 2006-01-05 |
| JP5280603B2 JP5280603B2 (ja) | 2013-09-04 |
Family
ID=23271590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003531978A Expired - Fee Related JP5280603B2 (ja) | 2001-10-01 | 2002-10-01 | 転移阻害のための方法 |
| JP2010107880A Pending JP2010209101A (ja) | 2001-10-01 | 2010-05-10 | 転移阻害のための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010107880A Pending JP2010209101A (ja) | 2001-10-01 | 2010-05-10 | 転移阻害のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6753328B2 (enExample) |
| EP (1) | EP1450814B1 (enExample) |
| JP (2) | JP5280603B2 (enExample) |
| AU (1) | AU2002362459B2 (enExample) |
| CA (1) | CA2462564C (enExample) |
| WO (1) | WO2003028642A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003028642A2 (en) * | 2001-10-01 | 2003-04-10 | Rhode Island Hospital, A Lifespan Partner | Methods of inhibiting metastases |
| AU2004232858B2 (en) | 2003-04-23 | 2009-07-09 | Mannkind Corporation | Hydraulically actuated pump for long duration medicament administration |
| WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| AU2007233231B2 (en) | 2006-03-30 | 2011-02-24 | Mannkind Corporation | Multi-cartridge fluid delivery device |
| RU2468796C2 (ru) * | 2006-09-07 | 2012-12-10 | Эд. Гайстлих Зёне Аг Фюр Хемише Индустри | Способ лечения рака костей |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| ES2711504T3 (es) | 2009-07-24 | 2019-05-06 | Rhode Island Hospital | Vacunas de células dendríticas para tumores que expresan asparaginil-beta-hidroxilasa |
| US11738120B1 (en) | 2022-04-14 | 2023-08-29 | Cormedix Inc. | Synthesis of taurolidine, purity profiles and polymorphs |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1124285A (en) | 1964-10-06 | 1968-08-21 | Geistlich Soehne Ag | Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them |
| GB1408010A (en) | 1972-11-20 | 1975-10-01 | Geistlich Soehne Ag | Sulphamoylphenyl-imidazolidinones |
| GB1557163A (en) | 1975-06-24 | 1979-12-05 | Geistlich Soehne Ag | Dental care preparations |
| US4107305A (en) | 1975-08-04 | 1978-08-15 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Treatment of endotoxaemia |
| GB1588110A (en) | 1978-05-31 | 1981-04-15 | Geistlich Soehne Ag | Pharmaceutical compositions for the treatment of scars |
| US4337251A (en) | 1979-05-09 | 1982-06-29 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of avoiding and removing adhesions |
| CA1190855A (en) | 1980-09-03 | 1985-07-23 | Rolf W. Pfirrmann | Treatment of osteitis |
| GB8328073D0 (en) | 1983-10-20 | 1983-11-23 | Geistlich Soehne Ag | Chemical compounds |
| GB8328074D0 (en) | 1983-10-20 | 1983-11-23 | Geistlich Soehne Ag | Chemical compositions |
| GB8328111D0 (en) | 1983-10-20 | 1983-11-23 | Geistlich Soehne Ag | Chemical compounds |
| GB8617482D0 (en) | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| US5210083A (en) | 1986-07-17 | 1993-05-11 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Pharmaceutical compositions |
| US5573771A (en) | 1988-08-19 | 1996-11-12 | Osteomedical Limited | Medicinal bone mineral products |
| US5069662A (en) * | 1988-10-21 | 1991-12-03 | Delcath Systems, Inc. | Cancer treatment |
| US5819748A (en) | 1988-11-30 | 1998-10-13 | Ed Geistlich Sohne Ag Fur Chemische Industrie | Implant for use in bone surgery |
| GB8827986D0 (en) | 1988-11-30 | 1989-01-05 | Geistlich Soehne Ag | Chemical product |
| GB9005856D0 (en) | 1990-03-15 | 1990-05-09 | Geistlich Soehne Ag | Compositions |
| GB9015108D0 (en) | 1990-07-09 | 1990-08-29 | Geistlich Soehne Ag | Chemical compositions |
| US5635532A (en) | 1991-10-21 | 1997-06-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia |
| GB9216155D0 (en) | 1992-07-30 | 1992-09-09 | Geistlich Soehne Ag | Treatment of dentoalveolar infections |
| US5954687A (en) | 1995-04-28 | 1999-09-21 | Medtronic, Inc. | Burr hole ring with catheter for use as an injection port |
| US5976822A (en) | 1995-05-18 | 1999-11-02 | Coulter International Corp. | Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis |
| GB9600426D0 (en) | 1996-01-10 | 1996-03-13 | Ed Geistlich Sohne A G | Compositions |
| WO1998052572A1 (en) | 1997-05-22 | 1998-11-26 | Oklahoma Medical Research Foundation | Use of taurolidine for treatment of leukemias |
| GB9716219D0 (en) * | 1997-07-31 | 1997-10-08 | Geistlich Soehne Ag | Prevention of metastases |
| US6479481B1 (en) | 1999-06-04 | 2002-11-12 | Ed. Geistlich Soehne Ag Fur Chemische Industrie | Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| US7151099B2 (en) * | 1998-07-31 | 2006-12-19 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases |
| US6011030A (en) | 1997-09-22 | 2000-01-04 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating symptoms of microbial infection or sepsis |
| US5972933A (en) | 1998-01-08 | 1999-10-26 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Method of treating microbial infections |
| US6117868A (en) | 1998-09-16 | 2000-09-12 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection |
| US20020098164A1 (en) * | 2000-10-27 | 2002-07-25 | Redmond H. Paul | Treatment of tumor metastases and cancer |
| SE516215C2 (sv) * | 1999-07-10 | 2001-12-03 | Argmed Kb | Perfusionssystem samt pumpanordning och styrsystem för användning i perfusionssystemet |
| JP2003515558A (ja) * | 1999-12-06 | 2003-05-07 | ロード アイランド ホスピタル， ア ライフスパン パートナー | 腫瘍を治療するためのメチロール含有化合物の使用 |
| CA2363973C (en) * | 2000-11-28 | 2009-03-10 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| WO2003028642A2 (en) * | 2001-10-01 | 2003-04-10 | Rhode Island Hospital, A Lifespan Partner | Methods of inhibiting metastases |
-
2002
- 2002-10-01 WO PCT/US2002/031079 patent/WO2003028642A2/en not_active Ceased
- 2002-10-01 JP JP2003531978A patent/JP5280603B2/ja not_active Expired - Fee Related
- 2002-10-01 AU AU2002362459A patent/AU2002362459B2/en not_active Ceased
- 2002-10-01 EP EP02800392.9A patent/EP1450814B1/en not_active Expired - Lifetime
- 2002-10-01 US US10/262,778 patent/US6753328B2/en not_active Expired - Lifetime
- 2002-10-01 CA CA2462564A patent/CA2462564C/en not_active Expired - Fee Related
-
2004
- 2004-06-21 US US10/873,802 patent/US7122541B2/en not_active Expired - Lifetime
-
2010
- 2010-05-10 JP JP2010107880A patent/JP2010209101A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007518723A5 (enExample) | ||
| AU2003222103A1 (en) | Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas | |
| EP1743038A4 (en) | MN / CA IX / CA9 AND KIDNEY CANCER PROGNOSIS | |
| FI20030967A0 (fi) | Yhteysasetusten valinta | |
| ZA200307450B (en) | Process for the production of synthesis gas. | |
| AU2003268052A8 (en) | Production of purified water and high value chemicals from salt water | |
| NO20053860D0 (no) | COP 1 for behandling av inflammatorisk tarmsykdom. | |
| EP1671998A3 (en) | Process to form compound with indolocarbazole moieties | |
| DE502005003904D1 (de) | Tetrahydrobenzo (d) azepin-2-on derivate und ihre verwendung zur behandlung von kardiovaskulären krankheiten | |
| JP2006507484A5 (enExample) | ||
| ATE491814T1 (de) | Herstellung von titanoxid | |
| FI20041250L (fi) | Massanhiutaloittaja | |
| NZ597857A (en) | Method and composition for treating mucosal disorders | |
| ATE399175T1 (de) | Hemmstoffe der urokinase, ihre herstellung und verwendung | |
| DE602004023786D1 (de) | Herstellung von hochreinem Alkylgallium | |
| NO20044050L (no) | Fremgangsmate for syntese av chirale N-aryl-piperaziner | |
| DE60220554D1 (de) | Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen | |
| IS7568A (is) | 1,3-díasa-díbensóasúlen sem latar æxlisdrepþáttarframleiðslu og milliefni til framleiðslu á þeim | |
| SE0950616L (sv) | Flerstegsframställning av mekanisk massa med AP genom blåslinjebehandling med raffinör | |
| NO20034597L (no) | Fremgangsmate for fremstilling av cantaxantin | |
| IS7566A (is) | 1-þía-3-asa-díbensóasúlen sem latar æxlisdrepþáttar framleiðslu og milliefni til framleiðslu á þeim | |
| ZA200703482B (en) | B7-H1 and methods of diagnosis, prognosis, and treatment of cancer | |
| DE50300920D1 (de) | Ferrocenylliganden und ein verfahren zur herstellung solcher liganden | |
| NO20050885D0 (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| DE60302455T2 (de) | Genussfähige emulsion mit lebenden mikroorganismen |